中科微点-全球专利检索

  1. Login
  2. Sign Up

Search Results

44 records (took 0.013 seconds)

    System for determining the exit direction of a flexible supply line from an autonomous mobile unit
    41.
    发明授权
    System for determining the exit direction of a flexible supply line from an autonomous mobile unit 失效
    用于确定来自自主移动单元的柔性供应线的出口方向的系统

    公开(公告)号：US5703297A

    公开(公告)日：1997-12-30

    申请号：US683226

    申请日：1996-07-18

    Applicant: Rudolf Bauer

    Inventor： Rudolf Bauer

    IPC: G05D1/02 ,  B65H75/44 ,  G01B7/004 ,  G01B7/312 ,  H02G1/06 ,  H02G9/10 ,  H02G11/02 ,  G01L7/00 ,  E03B1/00

    CPC classification number: B65H75/4484 ,  B65H75/4402 ,  G01B7/004 ,  G01B7/312 ,  H02G1/06 ,  H02G11/02 ,  H02G9/10

    Abstract: A system is provided for sensing an exit direction of a flexible supply line relative to an apparatus, such as robot or autonomous mobile unit. A method is also provided for planning the movement of such a unit based partly on such supply line direction data. The system includes a pressure sensor a least partially disposed around an exit opening through which the supply line is feedably guided. Upon contact at a given point on the sensor from the supply line, the sensor emits a signal corresponding to a particular exit direction. From this signal, a probable exit direction is inferred and a more precise movement planning is enabled, avoiding measurement errors that arise when the cable is run over can be avoided, or avoiding knottings of the cable.

    Abstract translation: 提供了一种用于感测柔性供应管线相对于诸如机器人或自主移动单元的装置的出口方向的系统。 还提供了一种用于基于这样的供应线方向数据来规划这种单元的移动的方法。 该系统包括压力传感器，该压力传感器至少部分地布置在出口周围，供给线通过该出口开放。 在传感器上的给定点处从供应线接触时，传感器发出对应于特定出口方向的信号。 从该信号中，可以推断可能的出口方向，并且启用更精确的运动规划，避免可以避免电缆运行时产生的测量误差，或避免电缆打结。

    Tetrahydro-benzthiazoles, the preparation thereof and their use as intermediate products or as pharmaceuticals
    43.
    发明授权
    Tetrahydro-benzthiazoles, the preparation thereof and their use as intermediate products or as pharmaceuticals 失效
    四氢 - 苯并噻唑，其制备方法及其作为中间产物或药物的用途

    公开(公告)号：US4843086A

    公开(公告)日：1989-06-27

    申请号：US124197

    申请日：1987-11-23

    Applicant: Gerhart Griss, deceased ,  Claus Schneider ,  Rudolf Hurnaus ,  Walter Kobinger ,  Ludwig Pichler ,  Rudolf Bauer ,  Joachim Mierau ,  Dieter Hinzen ,  Gunter Schingnitz

    Inventor： Gerhart Griss, deceased ,  Claus Schneider ,  Rudolf Hurnaus ,  Walter Kobinger ,  Ludwig Pichler ,  Rudolf Bauer ,  Joachim Mierau ,  Dieter Hinzen ,  Gunter Schingnitz

    IPC: A61K31/425 ,  C07D277/82

    CPC classification number: C07D277/82

    Abstract: This invention relates to new tetrahydrobenzthiazoles of general formula ##STR1## wherein R.sub.1 represents a hydrogen atom, an alkyl group, an alkenyl or alkynyl group, an alkanoyl group, a phenyl alkyl or phenyl alkanoyl group, while the above mentioned phenyl nuclei may each be substituted by 1 or 2 halogen atoms.R.sub.2 represents a hydrogen atom or an alkyl group,R.sub.3 represents a hydrogen atom, an alkyl group a cycloalkyl group, an alkenyl or alkynyl group, an alkanoyl group, a phenyl alkyl or phenyl alkanoyl group, while the phenyl nucleus may be substituted by fluorine, chlorine or bromine atoms,R.sub.4 represents a hydrogen atom, an alkyl group, an alkyl or alkenyl group, orR.sub.3 and R.sub.4 together with the nitrogen atom between them represent a pyrrolidino, piperidino, hexamethyleneimino or morpholino group, the enantiomers and the acid addition salts thereof.The compounds of general formula I above in which one of the groups R.sub.1 or R.sub.3 or both groups R.sub.1 and R.sub.3 represent an acyl group are valuable intermediate products for preparing the other compounds of general formula I which have valuable pharmacological properties. The new compounds may be prepared using methods known per se.

    Abstract translation: 本发明涉及通式为（I）的新的四氢苯并噻唑，其中R 1表示氢原子，烷基，烯基或炔基，烷酰基，苯基烷基或苯基烷酰基，而上述苯基核 可各自被1或2个卤素原子取代。 R2表示氢原子或烷基，R3表示氢原子，烷基，环烷基，烯基或炔基，烷酰基，苯基烷基或苯基烷酰基，而苯基核可以被氟取代 ，氯或溴原子，R4表示氢原子，烷基，烷基或烯基或R3和R4以及它们之间的氮原子表示吡咯烷子基，哌啶子基，六亚甲基亚氨基或吗啉代基，对映体和酸加成 的盐。 上述通式I的化合物，其中R1或R3基团或R1和R3两个基团之一表示酰基，是制备其它具有有价值的药理学性质的通式I化合物的有价值的中间产物。 新化合物可以使用本身已知的方法制备。

Patent Agency Ranking